Adjuvant systemic therapy in older women with breast cancer

Código QR

Adjuvant systemic therapy in older women with breast cancer

Julieta Leone,1 Bernardo Amadeo Leone,1 José Pablo Leone2 1Department of Medical Oncology, Grupo Oncológico Cooperativo del Sur (GOCS), Neuquén, Argentina; 2Department of Internal Medicine, Division of Hematology-Oncology and Blood & Marrow Transplantation, U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Leone J, Leone BA, Leone JP
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Breast Cancer Adjuvant Therapy Chemotherapy Endocrine Therapy Elderly. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/8a9ad08e60214e8889f202e54ed37e10
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Are another 5 years of adjuvant aromatase inhibitor therapy needed?
por: Mo QG, et al.
Publicado: (2016)

Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
por: Wako Z, et al.
Publicado: (2021)

Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
por: Zeleke Alem A, et al.
Publicado: (2020)

Resistance and Overcoming Resistance in Breast Cancer
por: Luque-Bolivar A, et al.
Publicado: (2020)

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani D, et al.
Publicado: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder T, et al.
Publicado: (2021)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
por: Yi-Kun Kang, et al.
Publicado: (2021)

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
por: Thompson MR, et al.
Publicado: (2021)

Prospects for the development of adjuvant therapy for non-small cell lung cancer
por: K. K. Laktionov, et al.
Publicado: (2020)

Adjuvant targeted therapy for non-small cell lung cancer
por: Konstantin K. Laktionov, et al.
Publicado: (2020)

Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
por: Venturelli M, et al.
Publicado: (2018)

A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Jiaojiao Suo, et al.
Publicado: (2021)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
por: Inna P. Ganshina, et al.
Publicado: (2021)

Hormone Therapy and Factors Affecting Fertility of Women Under 50-Year-Old with Breast Cancer
por: Moradinazar M, et al.
Publicado: (2019)

Comparison Of Accelerated Partial Breast Radiation Therapy And External Beam Radiation Therapy By Treatment Planning Indices
por: Hejazi P, et al.
Publicado: (2019)

A Prognostic Nomogram for T3N0 Rectal Cancer After Total Mesorectal Excision to Help Select Patients for Adjuvant Therapy
por: Chao Zhang, et al.
Publicado: (2021)

Statins and risk of breast cancer recurrence
por: Sakellakis M, et al.
Publicado: (2016)

TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer
por: Isabel Grote, et al.
Publicado: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
por: Matthias Balk, et al.
Publicado: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

An Insight into the Role of Bee Venom and Melittin Against Tumor Cells: A Review of Breast Cancer therapy
por: Roha Tariq, et al.
Publicado: (2021)

Genetic Influences in Breast Cancer Drug Resistance
por: Daniyal A, et al.
Publicado: (2021)

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
por: Sambi M, et al.
Publicado: (2017)

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
por: Roberta Maltoni, et al.
Publicado: (2022)

Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients
por: Yin Jin, et al.
Publicado: (2021)

Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study
por: Jianqiang Cai, et al.
Publicado: (2021)

Does the Presence of Cytokeratin Positive Individual Tumor Cells (N0(I+)) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation
por: Smith J, et al.
Publicado: (2021)

A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
por: Soliman H, et al.
Publicado: (2015)

Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy
por: Se Ik Kim, et al.
Publicado: (2021)

Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer
por: Savioli F, et al.
Publicado: (2021)

Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
por: Rokuro Morii, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis on the Number of Adjuvant Temozolomide Cycles in Newly Diagnosed Glioblastoma
por: Fahimeh Attarian, et al.
Publicado: (2021)

Awareness and current knowledge of breast cancer
por: Akram,Muhammad, et al.
Publicado: (2017)

Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent
por: Ozdemir BZ, et al.
Publicado: (2019)

Positive margins (R1) risk factors in breast cancer conservative surgery
por: Lombardi A, et al.
Publicado: (2019)

Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
por: Yizhao Xie, et al.
Publicado: (2021)

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
por: Kunnuru SKR, et al.
Publicado: (2020)

Variation in the management of elderly patients in two neighboring breast units is due to preferences and attitudes of health professionals
por: Morrow ES, et al.
Publicado: (2019)

Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
por: Irina V. Kolyadina, et al.
Publicado: (2020)